17 June 2024
11 March 2024
READ MOREAkston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility
26 February 2024
READ MOREAkston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility
31 August 2023
READ MOREAkston Biosciences Receives 2023 Most Innovative Award at Animal Health Summit
28 August 2023
READ MOREAkston Biosciences CEO to Present at the 2023 Animal Health Summit in Kansas City
17 August 2023
READ MOREAkston Biosciences to Focus on Strong Animal Health Pipeline
9 March 2023
READ MOREAkston Biosciences Strengthens Board with Addition of John T. Preston
9 February 2021
READ MOREAkston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC
22 July 2020
READ MOREAkston Biosciences Receives $2.5M Milestone Payment
9 April 2020